FDA Investigator

Peter E Baker

Latest inspection on record: Hangzhou, China, March 2018 · records back to 2008

Human DrugsAnimal Drugs & FeedsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 155 inspections across 142 sites are on record.
  • 320 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2018-03-06.

At a glance

Inspections

155

Sites

142

Observations

320

Career since

Dec 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Hisun Pharmaceutical (Hangzhou) Co., Ltd.6 Mar 2018Human DrugsOn file
Changzhou Siyao Pharmaceuticals Co Ltd17 Jan 2018Human Drugs
Henan Lihua Pharmaceutical Co., Ltd.14 Dec 2017Human DrugsOn file
Chongqing Carelife Pharmaceutical Co., Ltd.30 Nov 2017Human DrugsOn file
Sunshine Lake Pharma Co., Ltd.19 Oct 2017Human DrugsOn file

Sites inspected

Hisun Pharmaceutical (Hangzhou) Co., Ltd.Hangzhou, China1 insp.
Changzhou Siyao Pharmaceuticals Co LtdChangzhou City, China1 insp.
Henan Lihua Pharmaceutical Co., Ltd.Anyang, China1 insp.
Chongqing Carelife Pharmaceutical Co., Ltd.Chongqing, China1 insp.
Sunshine Lake Pharma Co., Ltd.Dongguan, China1 insp.

Co-investigators

Investigators who share inspections with this person.

CntrctMntr Phung14 shared
William V Millar11 shared
Dipesh K Shah10 shared
Christopher T Middendorf9 shared
Atul Agrawal7 shared
Daniel J Roberts5 shared
Jennifer L Johnson4 shared
Kevin P Foley4 shared

Full investigator report

Get the verbatim findings behind Peter E Baker's 320 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators